AHPRA Advertising Compliance for
Cosmetic medicine sits at the intersection of the strictest Australian advertising regulations. Every Instagram post, clinic website page, and patient communication is a compliance surface — and AHPRA is watching.
Can cosmetic injectors advertise before and after photos in Australia?
Technically, yes — but with severe restrictions that make most existing photo galleries non-compliant. Before-and-after images cannot create unreasonable expectations, must not function as de-facto testimonials, and must never reference Schedule 4 substances by name. The Compliance Sentinel scans your live pages for these violations monthly, while the Compliance Scalpel audits new content before you publish it.
Section 133 — Testimonials
Why your patient review wall is a regulatory liability
Section 133 of the Health Practitioner Regulation National Law prohibits the use of testimonials in advertising of regulated health services. For cosmetic injectors, this extends to Google review screenshots embedded on your website, Instagram story reshares of patient comments, and curated “patient journey” narratives.
AHPRA does not distinguish between a formal written endorsement and a casual social media comment you’ve reposted. If it conveys a patient’s experience of a clinical outcome and appears in your advertising, it is a testimonial — and it is prohibited. Penalties can reach $60,000 per offence for individuals.
Title & Specialist Restrictions
“Cosmetic Surgeon” is not always a protected title — but misuse still triggers investigations
Section 115A restricts the use of specialist titles to practitioners with AHPRA-recognised specialist registration. Cosmetic injectors who hold general registration cannot advertise as “cosmetic surgeons” or use language that implies surgical specialisation without meeting these requirements.
The Compliance Sentinel flags title misuse across every page of your website, including team bios, service descriptions, and structured data. It cites the exact clause so you can brief your web team with precision rather than guesswork.
TGA Schedule 4 Violations
Naming injectable products in advertising is a federal offence
The Therapeutic Goods Act and TGA Advertising Code prohibit advertising Schedule 4 prescription-only medicines to the public. For cosmetic injectors, this means you cannot name specific injectable products — including common brand names for botulinum toxin and dermal fillers — anywhere in your public-facing content.
This applies to your website, social media, Google Ads, clinic brochures, and even email newsletters sent to patients. TGA fines for corporations can reach $1.11 million. The Compliance Scalpel detects Schedule 4 brand references across all 26 supported content types and provides compliant replacement phrasing instantly.
Stop gambling with your registration
Whether you run a single-practitioner cosmetic clinic or a multi-location practice, every page and every post is a compliance surface. These tools do the checking so you don’t have to.